Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lophos Holdings Inc C.MESC

Lophos Holdings Inc. is a Canada-based company, which is engaged in the cultivation, research and sale of Lophophora williamsii (peyote cactus). The Company is also engaged in the research and development of compounds derived from the peyote cactus. Its cultivated peyote cactus will be used by the Company to conduct pre-clinical research and development in Canada either directly through a Controlled Substance Dealers License (CSDL) at its Napanee facility, or indirectly with one or more third-party partners. The Company's CSDL licensing includes the development of intellectual property related to the chemical composition of peyote and the custom formulation of Mescaline and related compounds and the research and development of drug delivery systems for Mescaline and other related molecules. It also operates a Health Canada licensed analytical testing and research and development institution, to conduct pre-clinical research and development through Sigma Analytical Services Inc.


CSE:MESC - Post by User

Lophos Holdings Inc > Trend Continues
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Post by TheMediaon Mar 29, 2024 3:29pm
112 Views
Post# 35960441

Trend Continues

Trend Continues
Yet again Feb13th Equity Guru writes up the stock it starts to nose dive. A trend on every stock Chris Parry writes up.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities